Mercer Susan L, Hassan Hazem E, Cunningham Christopher W, Eddington Natalie D, Coop Andrew
Department of Pharmaceutical Sciences, University of Maryland, School of Pharmacy, 20 Penn Street, Room 637, Baltimore, MD 21201, USA.
Bioorg Med Chem Lett. 2007 Mar 1;17(5):1160-2. doi: 10.1016/j.bmcl.2006.12.042. Epub 2006 Dec 21.
P-Glycoprotein (P-gp) is an efflux transporter which is up-regulated at the blood-brain barrier in both morphine- and oxycodone-tolerant rats. Numerous studies have shown that many clinically employed opioid analgesics are substrates for P-gp, suggesting that up-regulation of P-gp may contribute to the development of central tolerance to opioids. The studies herein focus on the development of SAR for P-gp substrate activity in the meperidine series of compounds, and show that a meperidine analog of greater potency, N-phenylbutyl-N-normeperidine, has low activity as a P-gp substrate and has the potential to be utilized as a tool to study the contribution of P-gp to the development of central tolerance to opioids.
P-糖蛋白(P-gp)是一种外排转运蛋白,在吗啡和羟考酮耐受的大鼠血脑屏障中上调。大量研究表明,许多临床使用的阿片类镇痛药是P-gp的底物,这表明P-gp的上调可能有助于阿片类药物中枢耐受性的形成。本文的研究集中于哌替啶系列化合物中P-gp底物活性的构效关系发展,并表明一种活性更强的哌替啶类似物N-苯基丁基-N-去甲哌替啶作为P-gp底物的活性较低,有潜力用作研究P-gp对阿片类药物中枢耐受性形成贡献的工具。